Esoprax 20 mg

Esoprax 20 mg is a medicine authorised by Swissmedic under authorisation number 66321. The authorisation holder is Drossapharm AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 12 July 2017 and the authorisation is valid without a time limit. ATC code A02BC05 places the medicine in the group Drugs for acid related disorders.

  • Dispensing category B
  • Authorisation number 66321
  • ATC A02BC05
  • Synthetic medicines
Authorisation data
Authorisation number66321
NameEsoprax 20 mg
Full nameEsoprax 20 mg, magensaftresistente Tabletten
Authorisation holderDrossapharm AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeA02BC05
First authorisation12 July 2017
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Esoprax 20 mg, magensaftresistente TablettenB12 July 2017
2Esoprax 40 mg, magensaftresistente TablettenB12 July 2017

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
114Tablette(n)A02BC0504.99.0.B
930Tablette(n)A02BC0504.99.0.B
1060Tablette(n)A02BC0504.99.0.B
11100Tablette(n)A02BC0504.99.0.B
1510Tablette(n)A02BC0504.99.0.B
514Tablette(n)A02BC0504.99.0.B
1230Tablette(n)A02BC0504.99.0.B
1360Tablette(n)A02BC0504.99.0.B
14100Tablette(n)A02BC0504.99.0.B
1610Tablette(n)A02BC0504.99.0.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Esoprax 20 mg authorised in Switzerland?

Yes. Esoprax 20 mg is authorised by Swissmedic under authorisation number 66321, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Esoprax 20 mg have?

Esoprax 20 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Esoprax 20 mg?

The authorisation holder is Drossapharm AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com